These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Maryland
|
|
52-2264646
|
|
(State of incorporation)
|
|
(I.R.S. Employer Identification No.)
|
|
Large accelerated filer
x
|
|
Accelerated filer
¨
|
|
Non-accelerated filer
¨
(do not check if smaller reporting company)
|
|
Smaller reporting company
¨
|
|
|
Emerging growth company
¨
|
|
|
|
|
Item 1.
|
Financial Statements.
|
|
|
|
3/31/2019
|
|
12/31/2018
|
||||
|
ASSETS
|
|
|
|
|
||||
|
Cash and cash equivalents
|
|
$
|
1,657.4
|
|
|
$
|
1,425.2
|
|
|
Accounts receivable and accrued revenue
|
|
604.6
|
|
|
549.6
|
|
||
|
Investments
|
|
2,546.7
|
|
|
2,453.4
|
|
||
|
Assets of consolidated T. Rowe Price investment products ($1,620.6 million at March 31, 2019 and $1,392.6 million at December 31, 2018, related to variable interest entities)
|
|
1,936.3
|
|
|
1,680.4
|
|
||
|
Operating lease assets
|
|
127.2
|
|
|
—
|
|
||
|
Property and equipment, net
|
|
667.2
|
|
|
661.3
|
|
||
|
Goodwill
|
|
665.7
|
|
|
665.7
|
|
||
|
Other assets
|
|
253.8
|
|
|
253.7
|
|
||
|
Total assets
|
|
$
|
8,458.9
|
|
|
$
|
7,689.3
|
|
|
|
|
|
|
|
||||
|
LIABILITIES
|
|
|
|
|
||||
|
Accounts payable and accrued expenses
|
|
$
|
210.0
|
|
|
$
|
228.5
|
|
|
Liabilities of consolidated T. Rowe Price investment products ($41.1 million at March 31, 2019 and $22.7 million at December 31, 2018, related to variable interest entities)
|
|
64.7
|
|
|
38.7
|
|
||
|
Operating lease liabilities
|
|
161.9
|
|
|
—
|
|
||
|
Accrued compensation and related costs
|
|
196.8
|
|
|
123.3
|
|
||
|
Supplemental savings plan liability
|
|
430.3
|
|
|
380.0
|
|
||
|
Income taxes payable
|
|
197.5
|
|
|
54.2
|
|
||
|
Total liabilities
|
|
1,261.2
|
|
|
824.7
|
|
||
|
|
|
|
|
|
||||
|
Commitments and contingent liabilities
|
|
|
|
|
|
|
||
|
|
|
|
|
|
||||
|
Redeemable non-controlling interests
|
|
886.7
|
|
|
740.3
|
|
||
|
|
|
|
|
|
||||
|
STOCKHOLDERS’ EQUITY
|
|
|
|
|
||||
|
Preferred stock, undesignated, $.20 par value – authorized and unissued 20,000,000 shares
|
|
—
|
|
|
—
|
|
||
|
Common stock, $.20 par value—authorized 750,000,000; issued 236,432,000 shares at March 31, 2019 and 238,069,000 at December 31, 2018
|
|
47.3
|
|
|
47.6
|
|
||
|
Additional capital in excess of par value
|
|
654.5
|
|
|
654.6
|
|
||
|
Retained earnings
|
|
5,650.8
|
|
|
5,464.1
|
|
||
|
Accumulated other comprehensive loss
|
|
(41.6
|
)
|
|
(42.0
|
)
|
||
|
Total permanent stockholders’ equity
|
|
6,311.0
|
|
|
6,124.3
|
|
||
|
Total liabilities, redeemable non-controlling interests, and permanent stockholders’ equity
|
|
$
|
8,458.9
|
|
|
$
|
7,689.3
|
|
|
|
Three months ended
|
||||||
|
|
3/31/2019
|
|
3/31/2018
|
||||
|
Revenues
|
|
|
|
||||
|
Investment advisory fees
|
$
|
1,194.2
|
|
|
$
|
1,189.2
|
|
|
Administrative, distribution, and servicing fees
|
133.1
|
|
|
138.8
|
|
||
|
Net revenues
|
1,327.3
|
|
|
1,328.0
|
|
||
|
|
|
|
|
||||
|
Operating expenses
|
|
|
|
||||
|
Compensation and related costs
|
491.5
|
|
|
441.4
|
|
||
|
Distribution and servicing
|
66.4
|
|
|
70.3
|
|
||
|
Advertising and promotion
|
21.6
|
|
|
24.6
|
|
||
|
Product-related costs
|
44.2
|
|
|
42.1
|
|
||
|
Technology, occupancy, and facility costs
|
98.1
|
|
|
94.1
|
|
||
|
General, administrative, and other
|
73.0
|
|
|
71.7
|
|
||
|
Total operating expenses
|
794.8
|
|
|
744.2
|
|
||
|
|
|
|
|
||||
|
Net operating income
|
532.5
|
|
|
583.8
|
|
||
|
|
|
|
|
||||
|
Non-operating income
|
|
|
|
||||
|
Net gains on investments
|
100.1
|
|
|
14.4
|
|
||
|
Net gains on consolidated investment products
|
101.9
|
|
|
.8
|
|
||
|
Other income
|
.8
|
|
|
.9
|
|
||
|
Total non-operating income
|
202.8
|
|
|
16.1
|
|
||
|
|
|
|
|
||||
|
Income before income taxes
|
735.3
|
|
|
599.9
|
|
||
|
Provision for income taxes
|
181.3
|
|
|
144.4
|
|
||
|
Net income
|
554.0
|
|
|
455.5
|
|
||
|
Less: net income attributable to redeemable non-controlling interests
|
41.4
|
|
|
1.8
|
|
||
|
Net income attributable to T. Rowe Price Group
|
$
|
512.6
|
|
|
$
|
453.7
|
|
|
|
|
|
|
||||
|
Earnings per share on common stock of T. Rowe Price Group
|
|
|
|
||||
|
Basic
|
$
|
2.11
|
|
|
$
|
1.81
|
|
|
Diluted
|
$
|
2.09
|
|
|
$
|
1.77
|
|
|
|
Three months ended
|
||||||
|
|
3/31/2019
|
|
3/31/2018
|
||||
|
Net income
|
$
|
554.0
|
|
|
$
|
455.5
|
|
|
Other comprehensive income (loss)
|
|
|
|
||||
|
Currency translation adjustments
|
|
|
|
||||
|
Consolidated T. Rowe Price investment products - variable interest entities
|
(5.8
|
)
|
|
16.2
|
|
||
|
Reclassification gains recognized in non-operating income upon deconsolidation of certain T. Rowe Price investment products
|
(.1
|
)
|
|
(3.1
|
)
|
||
|
Total currency translation adjustments of consolidated T. Rowe Price investment products - variable interest entities
|
(5.9
|
)
|
|
13.1
|
|
||
|
Equity method investments
|
4.9
|
|
|
3.8
|
|
||
|
Other comprehensive income (loss) before income taxes
|
(1.0
|
)
|
|
16.9
|
|
||
|
Net deferred tax benefits (income taxes)
|
.1
|
|
|
(2.5
|
)
|
||
|
Total other comprehensive income (loss)
|
(.9
|
)
|
|
14.4
|
|
||
|
|
|
|
|
||||
|
Total comprehensive income
|
553.1
|
|
|
469.9
|
|
||
|
Less: comprehensive income (loss) attributable to redeemable non-controlling interests
|
40.1
|
|
|
8.8
|
|
||
|
Total comprehensive income attributable to T. Rowe Price Group
|
$
|
513.0
|
|
|
$
|
461.1
|
|
|
|
Three months ended
|
||||||
|
|
3/31/2019
|
|
3/31/2018
|
||||
|
Cash flows from operating activities
|
|
|
|
||||
|
Net income
|
$
|
554.0
|
|
|
$
|
455.5
|
|
|
Adjustments to reconcile net income to net cash provided by (used in) operating activities
|
|
|
|
||||
|
Depreciation and amortization of property and equipment
|
41.9
|
|
|
36.9
|
|
||
|
Stock-based compensation expense
|
43.5
|
|
|
45.6
|
|
||
|
Net gains recognized on investments
|
(82.0
|
)
|
|
(2.6
|
)
|
||
|
Net investments in T. Rowe Price investment products used to economically hedge supplemental savings plan liability
|
(18.2
|
)
|
|
(12.9
|
)
|
||
|
Net change in securities held by consolidated T. Rowe Price investment products
|
(184.2
|
)
|
|
(189.4
|
)
|
||
|
Other changes in assets and liabilities
|
223.7
|
|
|
187.9
|
|
||
|
Net cash provided by operating activities
|
578.7
|
|
|
521.0
|
|
||
|
|
|
|
|
||||
|
Cash flows from investing activities
|
|
|
|
||||
|
Purchases of T. Rowe Price investment products
|
(15.6
|
)
|
|
(500.6
|
)
|
||
|
Dispositions T. Rowe Price investment products
|
33.5
|
|
|
37.2
|
|
||
|
Net cash of T. Rowe Price investment products on consolidation (deconsolidation)
|
(3.4
|
)
|
|
(21.5
|
)
|
||
|
Additions to property and equipment
|
(47.7
|
)
|
|
(36.7
|
)
|
||
|
Other investing activity
|
(.6
|
)
|
|
1.8
|
|
||
|
Net cash used in investing activities
|
(33.8
|
)
|
|
(519.8
|
)
|
||
|
|
|
|
|
||||
|
Cash flows from financing activities
|
|
|
|
||||
|
Repurchases of common stock
|
(231.0
|
)
|
|
(291.3
|
)
|
||
|
Common share issuances under stock-based compensation plans
|
43.6
|
|
|
46.2
|
|
||
|
Dividends paid to common stockholders of T. Rowe Price Group
|
(184.6
|
)
|
|
(174.8
|
)
|
||
|
Net subscriptions received from redeemable non-controlling interest holders
|
66.0
|
|
|
177.8
|
|
||
|
Net cash used in financing activities
|
(306.0
|
)
|
|
(242.1
|
)
|
||
|
|
|
|
|
||||
|
Effect of exchange rate changes on cash and cash equivalents of consolidated
T. Rowe Price investment products
|
(.7
|
)
|
|
1.3
|
|
||
|
|
|
|
|
||||
|
Net change in cash and cash equivalents during period
|
238.2
|
|
|
(239.6
|
)
|
||
|
Cash and cash equivalents at beginning of period, including $70.1 million at December 31, 2018, and $103.1 million at December 31, 2017, held by consolidated T. Rowe Price investment products
|
1,495.3
|
|
|
2,005.8
|
|
||
|
Cash and cash equivalents at end of period, including $76.1 million at March 31, 2019, and $84.8 million at March 31, 2018, held by consolidated T. Rowe Price investment products
|
$
|
1,733.5
|
|
|
$
|
1,766.2
|
|
|
|
Three months ended 3/31/2019
|
|||||||||||||||||||||||||
|
|
Common
shares outstanding |
|
Common
stock |
|
Additional
capital in excess of par value |
|
Retained
earnings |
|
AOCI
(1)
|
|
Total
stockholders’ equity |
|
Redeemable non-controlling interests
|
|||||||||||||
|
Balances at December 31, 2018
|
238,069
|
|
|
$
|
47.6
|
|
|
$
|
654.6
|
|
|
$
|
5,464.1
|
|
|
$
|
(42.0
|
)
|
|
$
|
6,124.3
|
|
|
$
|
740.3
|
|
|
Net income
|
—
|
|
|
—
|
|
|
—
|
|
|
512.6
|
|
|
—
|
|
|
512.6
|
|
|
41.4
|
|
||||||
|
Other comprehensive income (loss), net of tax
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
.4
|
|
|
.4
|
|
|
(1.3
|
)
|
||||||
|
Dividends declared ($0.76 per share)
|
—
|
|
|
—
|
|
|
—
|
|
|
(183.8
|
)
|
|
—
|
|
|
(183.8
|
)
|
|
—
|
|
||||||
|
Shares issued upon option exercises
|
830
|
|
|
.2
|
|
|
44.8
|
|
|
—
|
|
|
—
|
|
|
45.0
|
|
|
—
|
|
||||||
|
Net shares issued upon vesting of restricted stock units
|
14
|
|
|
—
|
|
|
(1.2
|
)
|
|
—
|
|
|
—
|
|
|
(1.2
|
)
|
|
—
|
|
||||||
|
Forfeiture of restricted awards
|
(5
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||||
|
Stock-based compensation expense
|
—
|
|
|
—
|
|
|
43.5
|
|
|
—
|
|
|
—
|
|
|
43.5
|
|
|
—
|
|
||||||
|
Common shares repurchased
|
(2,476
|
)
|
|
(.5
|
)
|
|
(87.2
|
)
|
|
(142.1
|
)
|
|
—
|
|
|
(229.8
|
)
|
|
—
|
|
||||||
|
Net subscriptions into T. Rowe Price investment products
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
85.9
|
|
||||||
|
Net reconsolidations of T. Rowe Price investment products
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
20.4
|
|
||||||
|
Balances at March 31, 2019
|
236,432
|
|
|
$
|
47.3
|
|
|
$
|
654.5
|
|
|
$
|
5,650.8
|
|
|
$
|
(41.6
|
)
|
|
$
|
6,311.0
|
|
|
$
|
886.7
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
|
|
Three months ended 3/31/2018
|
|||||||||||||||||||||||||
|
|
Common
shares outstanding |
|
Common
stock |
|
Additional
capital in excess of par value |
|
Retained
earnings |
|
AOCI
(1)
|
|
Total
stockholders’ equity |
|
Redeemable non-controlling interests
|
|||||||||||||
|
Balances at December 31, 2017
|
245,111
|
|
|
$
|
49.0
|
|
|
$
|
846.1
|
|
|
$
|
4,932.9
|
|
|
$
|
(3.6
|
)
|
|
$
|
5,824.4
|
|
|
$
|
992.8
|
|
|
Cumulative effect adjustment upon adoption of financial instruments and accumulated other comprehensive income guidance on January 1, 2018
(2)
|
—
|
|
|
—
|
|
|
—
|
|
|
22.4
|
|
|
(7.9
|
)
|
|
14.5
|
|
|
—
|
|
||||||
|
Reclassification of stranded tax benefits on currency translation adjustments on January 1, 2018
|
—
|
|
|
—
|
|
|
—
|
|
|
2.3
|
|
|
(2.3
|
)
|
|
—
|
|
|
—
|
|
||||||
|
Balances at January 1, 2018
|
245,111
|
|
|
49.0
|
|
|
846.1
|
|
|
4,957.6
|
|
|
(13.8
|
)
|
|
5,838.9
|
|
|
992.8
|
|
||||||
|
Net income
|
—
|
|
|
—
|
|
|
—
|
|
|
453.7
|
|
|
—
|
|
|
453.7
|
|
|
1.8
|
|
||||||
|
Other comprehensive income (loss), net of tax
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
7.4
|
|
|
7.4
|
|
|
7.0
|
|
||||||
|
Dividends declared ($0.70 per share)
|
—
|
|
|
—
|
|
|
—
|
|
|
(174.9
|
)
|
|
—
|
|
|
(174.9
|
)
|
|
—
|
|
||||||
|
Shares issued upon option exercises
|
1,103
|
|
|
.2
|
|
|
44.9
|
|
|
—
|
|
|
—
|
|
|
45.1
|
|
|
—
|
|
||||||
|
Net shares issued upon vesting of restricted stock units
|
6
|
|
|
—
|
|
|
(.4
|
)
|
|
—
|
|
|
—
|
|
|
(.4
|
)
|
|
—
|
|
||||||
|
Forfeiture of restricted awards
|
(4
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||||
|
Stock-based compensation expense
|
—
|
|
|
—
|
|
|
45.6
|
|
|
—
|
|
|
—
|
|
|
45.6
|
|
|
—
|
|
||||||
|
Restricted stock units issued as dividend equivalents
|
—
|
|
|
—
|
|
|
.1
|
|
|
(.1
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
||||||
|
Common shares repurchased
|
(2,934
|
)
|
|
(.5
|
)
|
|
(281.7
|
)
|
|
(31.3
|
)
|
|
—
|
|
|
(313.5
|
)
|
|
—
|
|
||||||
|
Net subscriptions into T. Rowe Price investment products
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
177.8
|
|
||||||
|
Net deconsolidations of T. Rowe Price investment products
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(632.9
|
)
|
||||||
|
Balances at March 31, 2018
|
243,282
|
|
|
$
|
48.7
|
|
|
$
|
654.6
|
|
|
$
|
5,205.0
|
|
|
$
|
(6.4
|
)
|
|
$
|
5,901.9
|
|
|
$
|
546.5
|
|
|
|
Three months ended 3/31/2019
|
|
Three months ended 3/31/2018
|
||||||||||||||||||||||||||||
|
|
|
|
Administrative, distribution, and servicing fees
|
|
|
|
|
|
Administrative, distribution, and servicing fees
|
|
|
||||||||||||||||||||
|
(in millions)
|
Investment advisory fees
|
|
Administrative fees
|
|
Distribution and servicing fees
|
|
Net revenues
|
|
Investment advisory fees
|
|
Administrative fees
|
|
Distribution and servicing fees
|
|
Net revenues
|
||||||||||||||||
|
U.S. mutual funds
|
$
|
815.9
|
|
|
$
|
76.6
|
|
|
$
|
30.2
|
|
|
$
|
922.7
|
|
|
$
|
832.9
|
|
|
$
|
81.8
|
|
|
$
|
36.6
|
|
|
$
|
951.3
|
|
|
Subadvised and separate accounts and other investment products
|
378.3
|
|
|
—
|
|
|
—
|
|
|
378.3
|
|
|
356.3
|
|
|
—
|
|
|
—
|
|
|
356.3
|
|
||||||||
|
Other clients
|
—
|
|
|
26.3
|
|
|
—
|
|
|
26.3
|
|
|
—
|
|
|
20.4
|
|
|
—
|
|
|
20.4
|
|
||||||||
|
|
$
|
1,194.2
|
|
|
$
|
102.9
|
|
|
$
|
30.2
|
|
|
$
|
1,327.3
|
|
|
$
|
1,189.2
|
|
|
$
|
102.2
|
|
|
$
|
36.6
|
|
|
$
|
1,328.0
|
|
|
|
Three months ended
|
||||||
|
(in millions)
|
3/31/2019
|
|
3/31/2018
|
||||
|
U.S. mutual funds
|
|
|
|
||||
|
Equity and blended assets
|
$
|
694.5
|
|
|
$
|
705.5
|
|
|
Fixed income, including money market
|
121.4
|
|
|
127.4
|
|
||
|
|
815.9
|
|
|
832.9
|
|
||
|
Subadvised and separate accounts and other investment products
|
|
|
|
||||
|
Equity and blended assets
|
318.8
|
|
|
297.0
|
|
||
|
Fixed income, including money market
|
59.5
|
|
|
59.3
|
|
||
|
|
378.3
|
|
|
356.3
|
|
||
|
Total
|
$
|
1,194.2
|
|
|
$
|
1,189.2
|
|
|
|
Average during
|
|
|
||||||||||||
|
|
Three months ended
|
|
As of
|
||||||||||||
|
(in billions)
|
3/31/2019
|
|
3/31/2018
|
|
3/31/2019
|
|
12/31/2018
|
||||||||
|
U.S. mutual funds
|
|
|
|
|
|
|
|
||||||||
|
Equity and blended assets
|
$
|
487.6
|
|
|
$
|
494.6
|
|
|
$
|
506.6
|
|
|
$
|
441.1
|
|
|
Fixed income, including money market
|
122.5
|
|
|
127.4
|
|
|
124.1
|
|
|
123.4
|
|
||||
|
|
610.1
|
|
|
622.0
|
|
|
630.7
|
|
|
564.5
|
|
||||
|
Subadvised and separate accounts and other investment products
|
|
|
|
|
|
|
|
||||||||
|
Equity and blended assets
|
332.9
|
|
|
308.2
|
|
|
347.9
|
|
|
299.2
|
|
||||
|
Fixed income, including money market
|
100.5
|
|
|
95.3
|
|
|
103.1
|
|
|
98.6
|
|
||||
|
|
433.4
|
|
|
403.5
|
|
|
451.0
|
|
|
397.8
|
|
||||
|
Total
|
$
|
1,043.5
|
|
|
$
|
1,025.5
|
|
|
$
|
1,081.7
|
|
|
$
|
962.3
|
|
|
(in millions)
|
3/31/2019
|
|
12/31/2018
|
||||
|
Investments held at fair value
|
|
|
|
||||
|
T. Rowe Price investment products
|
$
|
1,542.4
|
|
|
$
|
1,538.4
|
|
|
T. Rowe Price investment products designated as an economic hedge of supplemental savings plan liability
|
429.2
|
|
|
381.3
|
|
||
|
Investment partnerships and other investments
|
99.1
|
|
|
99.6
|
|
||
|
Equity method investments
|
|
|
|
||||
|
T. Rowe Price investment products
|
308.7
|
|
|
276.2
|
|
||
|
26% interest in UTI Asset Management Company Limited (India)
|
161.3
|
|
|
152.4
|
|
||
|
Investment partnerships and other investments
|
5.0
|
|
|
4.5
|
|
||
|
U.S. Treasury note
|
1.0
|
|
|
1.0
|
|
||
|
Total
|
$
|
2,546.7
|
|
|
$
|
2,453.4
|
|
|
|
Three months ended
|
||||||
|
(in millions)
|
3/31/2019
|
|
3/31/2018
|
||||
|
Net increase (decrease) in assets of consolidated T. Rowe Price investment products
|
$
|
12.3
|
|
|
$
|
(757.5
|
)
|
|
Net decrease in liabilities of consolidated T. Rowe Price investment products
|
$
|
(.9
|
)
|
|
$
|
(5.2
|
)
|
|
Net increase (decrease) in redeemable non-controlling interests
|
$
|
20.4
|
|
|
$
|
(632.9
|
)
|
|
|
|
|
|
||||
|
Gains recognized upon deconsolidation
|
$
|
.1
|
|
|
$
|
3.1
|
|
|
(in millions)
|
3/31/2019
|
|
12/31/2018
|
||||
|
Investment carrying values
|
$
|
141.1
|
|
|
$
|
143.3
|
|
|
Unfunded capital commitments
|
24.0
|
|
|
27.3
|
|
||
|
Uncollected investment advisory and administrative fees
|
8.1
|
|
|
5.2
|
|
||
|
|
$
|
173.2
|
|
|
$
|
175.8
|
|
|
|
securities, interest rates, prepayment speeds, and credit risk. These inputs are based on market data
|
|
|
3/31/2019
|
|
12/31/2018
|
||||||||||||
|
(in millions)
|
Level 1
|
|
Level 2
|
|
Level 1
|
|
Level 2
|
||||||||
|
Cash equivalents held in T. Rowe Price money market funds
|
$
|
1,398.3
|
|
|
$
|
—
|
|
|
$
|
1,196.0
|
|
|
$
|
—
|
|
|
T. Rowe Price investment products
|
1,964.1
|
|
|
7.5
|
|
|
1,900.5
|
|
|
19.2
|
|
||||
|
Total
|
$
|
3,362.4
|
|
|
$
|
7.5
|
|
|
$
|
3,096.5
|
|
|
$
|
19.2
|
|
|
|
3/31/2019
|
|
12/31/2018
|
||||||||||||||||||||
|
(in millions)
|
Voting
interest entities |
|
Variable interest entities
|
|
Total
|
|
Voting
interest entities |
|
Variable interest entities
|
|
Total
|
||||||||||||
|
Cash and cash equivalents
(1)
|
$
|
16.3
|
|
|
$
|
59.8
|
|
|
$
|
76.1
|
|
|
$
|
18.5
|
|
|
$
|
51.6
|
|
|
$
|
70.1
|
|
|
Investments
(2)
|
289.7
|
|
|
1,509.0
|
|
|
1,798.7
|
|
|
261.3
|
|
|
1,322.7
|
|
|
1,584.0
|
|
||||||
|
Other assets
|
9.7
|
|
|
51.8
|
|
|
61.5
|
|
|
8.0
|
|
|
18.3
|
|
|
26.3
|
|
||||||
|
Total assets
|
315.7
|
|
|
1,620.6
|
|
|
1,936.3
|
|
|
287.8
|
|
|
1,392.6
|
|
|
1,680.4
|
|
||||||
|
Liabilities
|
23.6
|
|
|
41.1
|
|
|
64.7
|
|
|
16.0
|
|
|
22.7
|
|
|
38.7
|
|
||||||
|
Net assets
|
$
|
292.1
|
|
|
$
|
1,579.5
|
|
|
$
|
1,871.6
|
|
|
$
|
271.8
|
|
|
$
|
1,369.9
|
|
|
$
|
1,641.7
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Attributable to T. Rowe Price Group
|
$
|
199.8
|
|
|
$
|
785.1
|
|
|
$
|
984.9
|
|
|
$
|
175.3
|
|
|
$
|
726.1
|
|
|
$
|
901.4
|
|
|
Attributable to redeemable non-controlling interests
|
92.3
|
|
|
794.4
|
|
|
886.7
|
|
|
96.5
|
|
|
643.8
|
|
|
740.3
|
|
||||||
|
|
$
|
292.1
|
|
|
$
|
1,579.5
|
|
|
$
|
1,871.6
|
|
|
$
|
271.8
|
|
|
$
|
1,369.9
|
|
|
$
|
1,641.7
|
|
|
|
Three months ended
|
||||||||||||||||||||||
|
|
3/31/2019
|
|
3/31/2018
|
||||||||||||||||||||
|
(in millions)
|
Voting interest entities
|
|
Variable interest entities
|
|
Total
|
|
Voting interest entities
|
|
Variable interest entities
|
|
Total
|
||||||||||||
|
Operating expenses reflected in net operating income
|
$
|
(.3
|
)
|
|
$
|
(2.8
|
)
|
|
$
|
(3.1
|
)
|
|
$
|
(.3
|
)
|
|
$
|
(2.2
|
)
|
|
$
|
(2.5
|
)
|
|
Net investment income (loss) reflected in non-operating income
|
8.0
|
|
|
93.9
|
|
|
101.9
|
|
|
(.8
|
)
|
|
1.6
|
|
|
.8
|
|
||||||
|
Impact on income before taxes
|
$
|
7.7
|
|
|
$
|
91.1
|
|
|
$
|
98.8
|
|
|
$
|
(1.1
|
)
|
|
$
|
(.6
|
)
|
|
$
|
(1.7
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Net income (loss) attributable to T. Rowe Price Group
|
$
|
8.7
|
|
|
$
|
48.7
|
|
|
$
|
57.4
|
|
|
$
|
(.7
|
)
|
|
$
|
(2.8
|
)
|
|
$
|
(3.5
|
)
|
|
Net income (loss) attributable to redeemable non-controlling interests
|
(1.0
|
)
|
|
42.4
|
|
|
41.4
|
|
|
(.4
|
)
|
|
2.2
|
|
|
1.8
|
|
||||||
|
|
$
|
7.7
|
|
|
$
|
91.1
|
|
|
$
|
98.8
|
|
|
$
|
(1.1
|
)
|
|
$
|
(.6
|
)
|
|
$
|
(1.7
|
)
|
|
|
Three months ended
|
||||||||||||||||||||||
|
|
3/31/2019
|
|
3/31/2018
|
||||||||||||||||||||
|
(in millions)
|
Voting
interest entities |
|
Variable interest entities
|
|
Total
|
|
Voting
interest entities |
|
Variable interest entities
|
|
Total
|
||||||||||||
|
Net cash provided by operating activities
|
$
|
(28.7
|
)
|
|
$
|
(65.0
|
)
|
|
$
|
(93.7
|
)
|
|
$
|
(52.8
|
)
|
|
$
|
(148.2
|
)
|
|
$
|
(201.0
|
)
|
|
Net cash used in investing activities
|
(5.1
|
)
|
|
1.7
|
|
|
(3.4
|
)
|
|
—
|
|
|
(21.5
|
)
|
|
(21.5
|
)
|
||||||
|
Net cash used in financing activities
|
31.6
|
|
|
72.2
|
|
|
103.8
|
|
|
63.4
|
|
|
139.5
|
|
|
202.9
|
|
||||||
|
Effect of exchange rate changes on cash and cash equivalents of consolidated
T. Rowe Price investment products |
—
|
|
|
(.7
|
)
|
|
(.7
|
)
|
|
—
|
|
|
1.3
|
|
|
1.3
|
|
||||||
|
Net change in cash and cash equivalents during period
|
(2.2
|
)
|
|
8.2
|
|
|
6.0
|
|
|
10.6
|
|
|
(28.9
|
)
|
|
(18.3
|
)
|
||||||
|
Cash and cash equivalents at beginning of year
|
18.5
|
|
|
51.6
|
|
|
70.1
|
|
|
7.1
|
|
|
96.0
|
|
|
103.1
|
|
||||||
|
Cash and cash equivalents at end of period
|
$
|
16.3
|
|
|
$
|
59.8
|
|
|
$
|
76.1
|
|
|
$
|
17.7
|
|
|
$
|
67.1
|
|
|
$
|
84.8
|
|
|
|
3/31/2019
|
|
12/31/2018
|
||||||||||||
|
(in millions)
|
Level 1
|
|
Level 2
|
|
Level 1
|
|
Level 2
|
||||||||
|
Assets
|
|
|
|
|
|
|
|
||||||||
|
Cash equivalents
|
$
|
15.3
|
|
|
$
|
—
|
|
|
$
|
19.3
|
|
|
$
|
—
|
|
|
Equity securities
|
239.9
|
|
|
572.6
|
|
|
189.6
|
|
|
483.5
|
|
||||
|
Fixed income securities
|
—
|
|
|
961.6
|
|
|
—
|
|
|
890.2
|
|
||||
|
Other investments
|
1.5
|
|
|
23.1
|
|
|
1.7
|
|
|
19.0
|
|
||||
|
|
$
|
256.7
|
|
|
$
|
1,557.3
|
|
|
$
|
210.6
|
|
|
$
|
1,392.7
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
Liabilities
|
$
|
(1.0
|
)
|
|
$
|
(9.7
|
)
|
|
$
|
(.8
|
)
|
|
$
|
(12.8
|
)
|
|
(in millions)
|
3/31/2019
|
||
|
2019 (excluding the first quarter ended March 31, 2019)
|
$
|
21.6
|
|
|
2020
|
29.8
|
|
|
|
2021
|
26.7
|
|
|
|
2022
|
22.4
|
|
|
|
2023
|
19.9
|
|
|
|
Thereafter
|
62.9
|
|
|
|
Total future undiscounted cash flows
|
183.3
|
|
|
|
Less: imputed interest to be recognized in lease expense
|
(21.4
|
)
|
|
|
Operating lease liabilities, as reported
|
$
|
161.9
|
|
|
|
Options
|
|
Weighted-
average
exercise
price
|
|||
|
Outstanding at December 31, 2018
|
11,300,393
|
|
|
$
|
69.05
|
|
|
Exercised
|
(972,655
|
)
|
|
$
|
60.26
|
|
|
Forfeited
|
(65,534
|
)
|
|
$
|
76.57
|
|
|
Expired
|
(7,807
|
)
|
|
$
|
59.07
|
|
|
Outstanding at March 31, 2019
|
10,254,397
|
|
|
$
|
69.84
|
|
|
Exercisable at March 31, 2019
|
8,272,310
|
|
|
$
|
68.24
|
|
|
|
Restricted
shares
|
|
Restricted
stock
units
|
|
Weighted-average
fair value
|
||||
|
Nonvested at December 31, 2018
|
136,964
|
|
|
6,603,920
|
|
|
$
|
87.07
|
|
|
Time-based grants
|
—
|
|
|
20,307
|
|
|
$
|
92.37
|
|
|
Vested
|
(400
|
)
|
|
(26,129
|
)
|
|
$
|
99.36
|
|
|
Forfeited
|
(4,928
|
)
|
|
(212,992
|
)
|
|
$
|
87.99
|
|
|
Nonvested at March 31, 2019
|
131,636
|
|
|
6,385,106
|
|
|
$
|
87.01
|
|
|
(in millions)
|
|
||
|
Second quarter 2019
|
$
|
49.0
|
|
|
Third quarter 2019
|
48.9
|
|
|
|
Fourth quarter 2019
|
43.8
|
|
|
|
2020
|
104.6
|
|
|
|
2021 through 2024
|
83.2
|
|
|
|
Total
|
$
|
329.5
|
|
|
|
Three months ended
|
||||||
|
(in millions)
|
3/31/2019
|
|
3/31/2018
|
||||
|
Net income attributable to T. Rowe Price Group
|
$
|
512.6
|
|
|
$
|
453.7
|
|
|
Less: net income allocated to outstanding restricted stock and stock unit holders
|
13.0
|
|
|
10.6
|
|
||
|
Net income allocated to common stockholders
|
$
|
499.6
|
|
|
$
|
443.1
|
|
|
|
|
|
|
||||
|
Weighted-average common shares
|
|
|
|
||||
|
Outstanding
|
236.6
|
|
|
244.3
|
|
||
|
Outstanding assuming dilution
|
239.6
|
|
|
249.8
|
|
||
|
|
Three months ended
|
||||||
|
(in millions)
|
3/31/2019
|
|
3/31/2018
|
||||
|
Net deferred tax benefits (income taxes) on:
|
|
|
|
||||
|
Currency translation adjustments
|
$
|
.1
|
|
|
$
|
(3.3
|
)
|
|
Reclassification adjustment recognized in the provision for income taxes upon deconsolidation of a T. Rowe Price investment product
|
—
|
|
|
.8
|
|
||
|
Total deferred tax benefits (income taxes) on currency translation adjustments
|
.1
|
|
|
(2.5
|
)
|
||
|
|
|
|
Currency translation adjustments
|
|
|
||||||||||||||
|
(in millions)
|
|
|
Equity method investments
|
|
Consolidated T. Rowe Price investment products - variable interest entities
|
|
Total currency translation adjustments
|
|
Total
|
||||||||||
|
Balances at December 31, 2018
|
|
|
$
|
(48.8
|
)
|
|
$
|
6.8
|
|
|
$
|
(42.0
|
)
|
|
$
|
(42.0
|
)
|
||
|
Other comprehensive income (loss) before reclassifications and income taxes
|
|
|
4.9
|
|
|
(4.5
|
)
|
|
.4
|
|
|
.4
|
|
||||||
|
Reclassification adjustments recognized in non-operating income
|
|
|
—
|
|
|
(.1
|
)
|
|
(.1
|
)
|
|
(.1
|
)
|
||||||
|
|
|
|
4.9
|
|
|
(4.6
|
)
|
|
.3
|
|
|
.3
|
|
||||||
|
Net deferred tax benefits (income taxes)
|
|
|
(1.1
|
)
|
|
1.2
|
|
|
.1
|
|
|
.1
|
|
||||||
|
Other comprehensive income (loss)
|
|
|
3.8
|
|
|
(3.4
|
)
|
|
.4
|
|
|
.4
|
|
||||||
|
Balances at March 31, 2019
|
|
|
$
|
(45.0
|
)
|
|
$
|
3.4
|
|
|
$
|
(41.6
|
)
|
|
$
|
(41.6
|
)
|
||
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
|
|
|
Currency translation adjustments
|
|
|
||||||||||||||
|
(in millions)
|
Net unrealized holding gains
|
|
Equity method investments
|
|
Consolidated T. Rowe Price investment products - variable interest entities
|
|
Total currency translation adjustments
|
|
Total
|
||||||||||
|
Balances at December 31, 2017
|
$
|
7.9
|
|
|
$
|
(30.6
|
)
|
|
$
|
19.1
|
|
|
$
|
(11.5
|
)
|
|
$
|
(3.6
|
)
|
|
Reclassification of unrealized holding gains to retained earnings upon adoption of new financial instruments guidance
(1)
|
(7.9
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(7.9
|
)
|
|||||
|
Reclassification adjustment of stranded tax benefits on currency translation adjustments upon adoption of new accumulated other comprehensive income guidance
|
—
|
|
|
(6.4
|
)
|
|
4.1
|
|
|
(2.3
|
)
|
|
(2.3
|
)
|
|||||
|
Balance at January 1, 2018
|
—
|
|
|
(37.0
|
)
|
|
23.2
|
|
|
(13.8
|
)
|
|
(13.8
|
)
|
|||||
|
Other comprehensive income before reclassifications and income taxes
|
—
|
|
|
3.8
|
|
|
9.2
|
|
|
13.0
|
|
|
13.0
|
|
|||||
|
Reclassification adjustments recognized in non-operating income
|
—
|
|
|
—
|
|
|
(3.1
|
)
|
|
(3.1
|
)
|
|
(3.1
|
)
|
|||||
|
|
—
|
|
|
3.8
|
|
|
6.1
|
|
|
9.9
|
|
|
9.9
|
|
|||||
|
Net deferred income taxes
|
—
|
|
|
(.8
|
)
|
|
(1.7
|
)
|
|
(2.5
|
)
|
|
(2.5
|
)
|
|||||
|
Other comprehensive income (loss)
|
—
|
|
|
3.0
|
|
|
4.4
|
|
|
7.4
|
|
|
7.4
|
|
|||||
|
Balances at March 31, 2018
|
$
|
—
|
|
|
$
|
(34.0
|
)
|
|
$
|
27.6
|
|
|
$
|
(6.4
|
)
|
|
$
|
(6.4
|
)
|
|
Item 2.
|
Management’s Discussion and Analysis of Financial Condition and Results of Operations.
|
|
Index
|
|
3/31/2019
|
|
S&P 500 Index
|
|
13.7%
|
|
NASDAQ Composite Index
(1)
|
|
16.5%
|
|
Russell 2000 Index
|
|
14.6%
|
|
MSCI EAFE (Europe, Australasia, and Far East) Index
|
|
10.1%
|
|
MSCI Emerging Markets Index
|
|
10.0%
|
|
Index
|
|
3/31/2019
|
|
Bloomberg Barclays U.S. Aggregate Bond Index
|
|
2.9%
|
|
JPMorgan Global High Yield Index
|
|
7.1%
|
|
Bloomberg Barclays Municipal Bond Index
|
|
2.9%
|
|
Bloomberg Barclays Global Aggregate Ex-U.S. Dollar Bond Index
|
|
1.5%
|
|
JPMorgan Emerging Markets Bond Index Plus
|
|
6.2%
|
|
|
Three months ended 3/31/2019
|
||||||||||||||
|
(in billions)
|
U.S. mutual funds
|
|
Subadvised and separate accounts
|
|
Other investment products
|
|
Total
|
||||||||
|
Assets under management at beginning of period
|
$
|
564.5
|
|
|
$
|
250.0
|
|
|
$
|
147.8
|
|
|
$
|
962.3
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
Net cash flows before client transfers
|
4.6
|
|
|
.8
|
|
|
—
|
|
|
5.4
|
|
||||
|
Client transfers
|
(6.1
|
)
|
|
(.9
|
)
|
|
7.0
|
|
|
—
|
|
||||
|
Net cash flows after client transfers
|
(1.5
|
)
|
|
(.1
|
)
|
|
7.0
|
|
|
5.4
|
|
||||
|
Net market appreciation and income
|
67.4
|
|
|
30.7
|
|
|
15.6
|
|
|
113.7
|
|
||||
|
Distributions reinvested
|
.3
|
|
|
—
|
|
|
—
|
|
|
.3
|
|
||||
|
Change during the period
|
66.2
|
|
|
30.6
|
|
|
22.6
|
|
|
119.4
|
|
||||
|
|
|
|
|
|
|
|
|
||||||||
|
Assets under management at March 31, 2019
|
$
|
630.7
|
|
|
$
|
280.6
|
|
|
$
|
170.4
|
|
|
$
|
1,081.7
|
|
|
|
Three months ended 3/31/2019
|
||||||||||||||
|
(in billions)
|
Equity
|
|
Fixed income, including money market
|
|
Multi-asset
(1)
|
|
Total
|
||||||||
|
Assets under management at beginning of period
|
$
|
539.9
|
|
|
$
|
136.1
|
|
|
$
|
286.3
|
|
|
$
|
962.3
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
Net cash flows
|
.7
|
|
|
1.5
|
|
|
3.2
|
|
|
5.4
|
|
||||
|
Net market appreciation and income
(2)
|
81.0
|
|
|
3.3
|
|
|
29.7
|
|
|
114.0
|
|
||||
|
Change during the period
|
81.7
|
|
|
4.8
|
|
|
32.9
|
|
|
119.4
|
|
||||
|
Assets under management at March 31, 2019
|
$
|
621.6
|
|
|
$
|
140.9
|
|
|
$
|
319.2
|
|
|
$
|
1,081.7
|
|
|
|
As of
|
||||||
|
(in billions)
|
3/31/2019
|
|
12/31/2018
|
||||
|
Target date retirement U.S. mutual funds
|
$
|
156.6
|
|
|
$
|
144.8
|
|
|
Target date separately managed retirement accounts
|
6.8
|
|
|
5.9
|
|
||
|
Target date retirement trusts
|
94.4
|
|
|
79.7
|
|
||
|
|
$
|
257.8
|
|
|
$
|
230.4
|
|
|
|
|
1 year
|
|
3 years
|
|
5 years
|
|
10 years
|
|
Outperformed Morningstar median
|
|
|
|
|
|
|
|
|
|
All funds
|
|
65%
|
|
68%
|
|
79%
|
|
82%
|
|
Multi-asset funds
|
|
86%
|
|
79%
|
|
88%
|
|
84%
|
|
|
|
|
|
|
|
|
|
|
|
Top Morningstar quartile
|
|
|
|
|
|
|
|
|
|
All funds
|
|
26%
|
|
39%
|
|
51%
|
|
54%
|
|
Multi-asset funds
|
|
3%
|
|
53%
|
|
59%
|
|
79%
|
|
|
Three months ended
|
|
Q1 2019 vs. Q1 2018
|
|||||||||||
|
(in millions, except per-share data)
|
3/31/2019
|
|
3/31/2018
|
|
$ change
|
|
% change
|
|||||||
|
U.S. GAAP basis
|
|
|
|
|
|
|
|
|||||||
|
Investment advisory fees
|
$
|
1,194.2
|
|
|
$
|
1,189.2
|
|
|
$
|
5.0
|
|
|
.4
|
%
|
|
Net revenues
|
$
|
1,327.3
|
|
|
$
|
1,328.0
|
|
|
$
|
(.7
|
)
|
|
(.1
|
)%
|
|
Operating expenses
|
$
|
794.8
|
|
|
$
|
744.2
|
|
|
$
|
50.6
|
|
|
6.8
|
%
|
|
Net operating income
|
$
|
532.5
|
|
|
$
|
583.8
|
|
|
$
|
(51.3
|
)
|
|
(8.8
|
)%
|
|
Non-operating income
(1)
|
$
|
202.8
|
|
|
$
|
16.1
|
|
|
$
|
186.7
|
|
|
n/m
|
|
|
Net income attributable to T. Rowe Price Group
|
$
|
512.6
|
|
|
$
|
453.7
|
|
|
$
|
58.9
|
|
|
13.0
|
%
|
|
Diluted earnings per common share
|
$
|
2.09
|
|
|
$
|
1.77
|
|
|
$
|
.32
|
|
|
18.1
|
%
|
|
Weighted average common shares outstanding assuming dilution
|
239.6
|
|
|
249.8
|
|
|
(10.2
|
)
|
|
(4.1
|
)%
|
|||
|
|
|
|
|
|
|
|
|
|||||||
|
Adjusted non-GAAP basis
(2)
|
|
|
|
|
|
|
|
|||||||
|
Operating expenses
|
$
|
756.6
|
|
|
$
|
741.0
|
|
|
$
|
15.6
|
|
|
2.1
|
%
|
|
Net income attributable to T. Rowe Price Group
|
$
|
460.6
|
|
|
$
|
445.6
|
|
|
$
|
15.0
|
|
|
3.4
|
%
|
|
Diluted earnings per common share
|
$
|
1.87
|
|
|
$
|
1.74
|
|
|
$
|
.13
|
|
|
7.5
|
%
|
|
|
|
|
|
|
|
|
|
|||||||
|
Assets under management (in billions)
|
|
|
|
|
|
|
|
|||||||
|
Average assets under management
|
$
|
1,043.5
|
|
|
$
|
1,025.5
|
|
|
$
|
18.0
|
|
|
1.8
|
%
|
|
Ending assets under management
|
$
|
1,081.7
|
|
|
$
|
1,014.2
|
|
|
$
|
67.5
|
|
|
6.7
|
%
|
|
|
Three months ended
|
|
Q1 2019 vs. Q1 2018
|
|||||||||||
|
(in millions)
|
3/31/2019
|
|
3/31/2018
|
|
$ change
|
|
% change
|
|||||||
|
Investment advisory fees
|
|
|
|
|
|
|
|
|||||||
|
U.S. mutual funds
|
$
|
815.9
|
|
|
$
|
832.9
|
|
|
$
|
(17.0
|
)
|
|
(2.0
|
)%
|
|
Subadvised and separate accounts and other investment products
|
378.3
|
|
|
356.3
|
|
|
22.0
|
|
|
6.2
|
%
|
|||
|
|
1,194.2
|
|
|
1,189.2
|
|
|
5.0
|
|
|
.4
|
%
|
|||
|
Administrative, distribution, and servicing fees
|
|
|
|
|
|
|
|
|||||||
|
Administrative fees
|
102.9
|
|
|
102.2
|
|
|
.7
|
|
|
.7
|
%
|
|||
|
Distribution and servicing fees
|
30.2
|
|
|
36.6
|
|
|
(6.4
|
)
|
|
(17.5
|
)%
|
|||
|
|
133.1
|
|
|
138.8
|
|
|
(5.7
|
)
|
|
(4.1
|
)%
|
|||
|
Net revenues
|
$
|
1,327.3
|
|
|
$
|
1,328.0
|
|
|
$
|
(.7
|
)
|
|
(.1
|
)%
|
|
|
Three months ended
|
|
Q1 2019 vs. Q1 2018
|
|||||||||||
|
(in millions)
|
3/31/2019
|
|
3/31/2018
|
|
$ change
|
|
% change
|
|||||||
|
Compensation and related costs
|
$
|
491.5
|
|
|
$
|
441.4
|
|
|
$
|
50.1
|
|
|
11.4
|
%
|
|
Distribution and servicing
|
66.4
|
|
|
70.3
|
|
|
(3.9
|
)
|
|
(5.5
|
)%
|
|||
|
Advertising and promotion
|
21.6
|
|
|
24.6
|
|
|
(3.0
|
)
|
|
(12.2
|
)%
|
|||
|
Product-related costs
|
44.2
|
|
|
42.1
|
|
|
2.1
|
|
|
5.0
|
%
|
|||
|
Technology, occupancy, and facility costs
|
98.1
|
|
|
94.1
|
|
|
4.0
|
|
|
4.3
|
%
|
|||
|
General, administrative, and other
|
73.0
|
|
|
71.7
|
|
|
1.3
|
|
|
1.8
|
%
|
|||
|
Total operating expenses
|
$
|
794.8
|
|
|
$
|
744.2
|
|
|
$
|
50.6
|
|
|
6.8
|
%
|
|
|
Three months ended
|
||||||
|
|
3/31/2019
|
|
|
3/31/2018
|
|
||
|
Net gains (losses) from non-consolidated T. Rowe Price investment products
|
|
|
|
||||
|
Cash and discretionary investments
|
|
|
|
||||
|
Dividend income
|
$
|
16.2
|
|
|
$
|
6.8
|
|
|
Market related gains (losses) and equity in earnings
|
28.0
|
|
|
(2.5
|
)
|
||
|
Seed capital investments
|
|
|
|
||||
|
Dividend income
|
.5
|
|
|
1.1
|
|
||
|
Market related gains (losses) and equity in earnings
|
19.6
|
|
|
(.4
|
)
|
||
|
Net gain recognized upon deconsolidation
|
.1
|
|
|
3.1
|
|
||
|
Investments used to hedge the supplemental savings plan liability
|
31.0
|
|
|
2.9
|
|
||
|
Total net gains from non-consolidated T. Rowe Price investment products
|
95.4
|
|
|
11.0
|
|
||
|
Other investment income
|
4.7
|
|
|
3.4
|
|
||
|
Net gains on investments
|
100.1
|
|
|
14.4
|
|
||
|
Net gains on consolidated sponsored investment portfolios
|
101.9
|
|
|
.8
|
|
||
|
Other income, including foreign currency gains and losses
|
.8
|
|
|
.9
|
|
||
|
Non-operating income
|
$
|
202.8
|
|
|
$
|
16.1
|
|
|
|
Three months ended
|
||||||
|
(in millions)
|
3/31/2019
|
|
3/31/2018
|
||||
|
Operating expenses reflected in net operating income
|
$
|
(3.1
|
)
|
|
$
|
(2.5
|
)
|
|
Net investment income reflected in non-operating income
|
101.9
|
|
|
.8
|
|
||
|
Impact on income before taxes
|
$
|
98.8
|
|
|
$
|
(1.7
|
)
|
|
|
|
|
|
||||
|
Net income attributable to our interest in the consolidated T. Rowe Price investment products
|
$
|
57.4
|
|
|
$
|
(3.5
|
)
|
|
Net income attributable to redeemable non-controlling interests (unrelated third-party investors)
|
41.4
|
|
|
1.8
|
|
||
|
|
$
|
98.8
|
|
|
$
|
(1.7
|
)
|
|
|
Three months ended
|
||||
|
|
3/31/2019
|
|
3/31/2018
|
||
|
Statutory U.S. federal income tax rate
|
21.0
|
%
|
|
21.0
|
%
|
|
State income taxes for current year, net of federal income tax benefits
(1)
|
4.2
|
|
|
5.1
|
|
|
Net income attributable to redeemable non-controlling interests
|
(.6
|
)
|
|
(.3
|
)
|
|
Net excess tax benefits from stock-based compensation plans activity
|
(.6
|
)
|
|
(2.1
|
)
|
|
Other items
|
.7
|
|
|
.4
|
|
|
Effective income tax rate
|
24.7
|
%
|
|
24.1
|
%
|
|
|
Three months ended
|
||||||
|
(in millions, except per-share amounts)
|
3/31/2019
|
|
3/31/2018
|
||||
|
Operating expenses, GAAP basis
|
$
|
794.8
|
|
|
$
|
744.2
|
|
|
Non-GAAP adjustments:
|
|
|
|
||||
|
Expenses of consolidated T. Rowe Price investment products, net of elimination of its related management and administrative fees
(1)
|
(1.6
|
)
|
|
(.8
|
)
|
||
|
Compensation expense related to market valuation changes in the supplemental savings plan liability
(2)
|
(36.6
|
)
|
|
(2.4
|
)
|
||
|
Adjusted operating expenses
|
$
|
756.6
|
|
|
$
|
741.0
|
|
|
|
|
|
|
||||
|
Net income attributable to T. Rowe Price Group, GAAP basis
|
$
|
512.6
|
|
|
$
|
453.7
|
|
|
Non-GAAP adjustments:
|
|
|
|
||||
|
Net income of consolidated T. Rowe Price investment products, net of redeemable non-controlling interests
(1)
|
(57.4
|
)
|
|
3.5
|
|
||
|
Non-operating income of investments designated as an economic hedge of the supplemental savings plan liability less related compensation expense
(2)
|
5.6
|
|
|
(.5
|
)
|
||
|
Other non-operating income
(3)
|
(25.7
|
)
|
|
(12.4
|
)
|
||
|
Income tax impacts of non-GAAP adjustments
(4)
|
25.5
|
|
|
1.3
|
|
||
|
Adjusted net income attributable to T. Rowe Price Group
|
$
|
460.6
|
|
|
$
|
445.6
|
|
|
|
|
|
|
||||
|
Diluted earnings per common share, GAAP basis
|
$
|
2.09
|
|
|
$
|
1.77
|
|
|
Non-GAAP adjustments:
|
|
|
|
||||
|
Consolidated T. Rowe Price investment products
(1)
|
(.16
|
)
|
|
.01
|
|
||
|
Non-operating income of investments designated as an economic hedge of the supplemental savings plan liability less related compensation expense
(2)
|
.01
|
|
|
—
|
|
||
|
Other non-operating income
(3)
|
(.07
|
)
|
|
(.04
|
)
|
||
|
Adjusted diluted earnings per common share
(5)
|
$
|
1.87
|
|
|
$
|
1.74
|
|
|
|
Three months ended
|
||||||
|
|
3/31/2019
|
|
3/31/2018
|
||||
|
Operating expenses before eliminations
|
$
|
3.1
|
|
|
$
|
2.5
|
|
|
Operating expenses eliminated in consolidation
|
(1.5
|
)
|
|
(1.7
|
)
|
||
|
Total operating expenses, net of eliminations
|
$
|
1.6
|
|
|
$
|
.8
|
|
|
|
Three months ended
|
||||||
|
|
3/31/2019
|
|
3/31/2018
|
||||
|
Net investment gains
|
$
|
101.9
|
|
|
$
|
.8
|
|
|
Operating expenses
|
(3.1
|
)
|
|
(2.5
|
)
|
||
|
Net income
|
98.8
|
|
|
(1.7
|
)
|
||
|
Less: net income attributable to redeemable non-controlling interests
|
41.4
|
|
|
1.8
|
|
||
|
T. Rowe Price Group's portion of net income
|
$
|
57.4
|
|
|
$
|
(3.5
|
)
|
|
|
Three months ended
|
||||||
|
|
3/31/2019
|
|
3/31/2018
|
||||
|
Net gains on investments designated as an economic hedge of supplemental savings plan liability
|
$
|
31.0
|
|
|
$
|
2.9
|
|
|
Compensation expense from market valuation changes in supplemental savings plan liability
|
(36.6
|
)
|
|
(2.4
|
)
|
||
|
Non-operating income (loss) of investments designated as an economic hedge of supplemental savings plan liability less compensation expense
|
$
|
(5.6
|
)
|
|
$
|
.5
|
|
|
|
Three months ended
|
||||||
|
|
3/31/2019
|
|
3/31/2018
|
||||
|
Net gains on investments
|
$
|
100.1
|
|
|
$
|
14.4
|
|
|
Less: net gains on investments designated as an economic hedge of supplemental savings plan liability
|
31.0
|
|
|
2.9
|
|
||
|
Less: net gains earned on cash and discretionary investments
|
44.2
|
|
|
—
|
|
||
|
Net gains on remaining non-consolidated investment portfolio
|
$
|
24.9
|
|
|
$
|
11.5
|
|
|
Other income
|
.8
|
|
|
.9
|
|
||
|
Total other non-operating income
|
$
|
25.7
|
|
|
$
|
12.4
|
|
|
(in millions)
|
|
3/31/2019
|
|
12/31/2018
|
||||
|
Cash and cash equivalents
|
|
$
|
1,657.4
|
|
|
$
|
1,425.2
|
|
|
Discretionary investments
|
|
1,720.2
|
|
|
1,597.1
|
|
||
|
Total cash and discretionary investments
|
|
3,377.6
|
|
|
3,022.3
|
|
||
|
Redeemable seed capital investments
|
|
1,115.8
|
|
|
1,118.9
|
|
||
|
Investments used to hedge the supplemental savings plan liability
|
|
429.2
|
|
|
381.3
|
|
||
|
Total cash and investments in T. Rowe Price products
|
|
$
|
4,922.6
|
|
|
$
|
4,522.5
|
|
|
(in millions)
|
|
Cash and cash equivalents
|
|
Investments
|
|
Net assets of consolidated T. Rowe Price investment products
|
|
3/31/2019
|
||||||||
|
Cash and discretionary investments
|
|
$
|
1,657.4
|
|
|
$
|
1,609.8
|
|
|
$
|
110.4
|
|
|
$
|
3,377.6
|
|
|
Seed capital investments
|
|
—
|
|
|
241.3
|
|
|
874.5
|
|
|
1,115.8
|
|
||||
|
Investments used to hedge the supplemental savings plan liability
|
|
—
|
|
|
429.2
|
|
|
—
|
|
|
429.2
|
|
||||
|
Total cash and investments in T. Rowe Price products attributable to T. Rowe Price Group
|
|
1,657.4
|
|
|
2,280.3
|
|
|
984.9
|
|
|
4,922.6
|
|
||||
|
Investment in UTI and other investments
|
|
—
|
|
|
266.4
|
|
|
—
|
|
|
266.4
|
|
||||
|
Total cash and investments attributable to T. Rowe Price Group
|
|
1,657.4
|
|
|
2,546.7
|
|
|
984.9
|
|
|
5,189.0
|
|
||||
|
Redeemable non-controlling interests
|
|
—
|
|
|
—
|
|
|
886.7
|
|
|
886.7
|
|
||||
|
As reported on unaudited condensed consolidated balance sheet at March 31, 2019
|
|
$
|
1,657.4
|
|
|
$
|
2,546.7
|
|
|
$
|
1,871.6
|
|
|
$
|
6,075.7
|
|
|
(in millions)
|
Recurring dividend
|
|
Stock repurchases
|
|
Total cash returned to stockholders
|
||||||
|
2017
|
$
|
562.6
|
|
|
$
|
458.1
|
|
|
$
|
1,020.7
|
|
|
2018
|
694.7
|
|
|
1,099.6
|
|
|
1,794.3
|
|
|||
|
Three months ended 3/31/2019
|
183.8
|
|
|
229.8
|
|
|
413.6
|
|
|||
|
Total
|
$
|
1,441.1
|
|
|
$
|
1,787.5
|
|
|
$
|
3,228.6
|
|
|
|
Three months ended
|
||||||||||||||||||||||||||||||
|
|
3/31/2019
|
|
3/31/2018
|
||||||||||||||||||||||||||||
|
(in millions)
|
Cash flow attributable to T. Rowe Price Group
|
|
Cash flow attributable to consolidated T. Rowe Price investment products
|
|
Elims
|
|
As reported
|
|
Cash flow attributable to T. Rowe Price Group
|
|
Cash flow attributable to consolidated T. Rowe Price investment products
|
|
Elims
|
|
As reported
|
||||||||||||||||
|
Cash flows from operating activities
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
|
Net income
|
$
|
512.6
|
|
|
$
|
98.8
|
|
|
$
|
(57.4
|
)
|
|
$
|
554.0
|
|
|
$
|
453.7
|
|
|
$
|
(1.7
|
)
|
|
$
|
3.5
|
|
|
$
|
455.5
|
|
|
Adjustments to reconcile net income to net cash provided by (used in) operating activities
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
|
Depreciation and amortization of property and equipment
|
41.9
|
|
|
—
|
|
|
|
|
41.9
|
|
|
36.9
|
|
|
—
|
|
|
—
|
|
|
36.9
|
|
|||||||||
|
Stock-based compensation expense
|
43.5
|
|
|
—
|
|
|
|
|
43.5
|
|
|
45.6
|
|
|
—
|
|
|
—
|
|
|
45.6
|
|
|||||||||
|
Net gains recognized on investments
|
(139.4
|
)
|
|
—
|
|
|
57.4
|
|
|
(82.0
|
)
|
|
.9
|
|
|
—
|
|
|
(3.5
|
)
|
|
(2.6
|
)
|
||||||||
|
Net investments in T. Rowe Price investment products used to economically hedge supplemental savings plan liability
|
(18.2
|
)
|
|
—
|
|
|
|
|
(18.2
|
)
|
|
(12.9
|
)
|
|
—
|
|
|
—
|
|
|
(12.9
|
)
|
|||||||||
|
Net change in trading securities held by consolidated T. Rowe Price investment products
|
—
|
|
|
(184.2
|
)
|
|
|
|
(184.2
|
)
|
|
—
|
|
|
(189.4
|
)
|
|
—
|
|
|
(189.4
|
)
|
|||||||||
|
Other changes in assets and liabilities
|
233.0
|
|
|
(8.3
|
)
|
|
(1.0
|
)
|
|
223.7
|
|
|
198.7
|
|
|
(9.9
|
)
|
|
(.9
|
)
|
|
187.9
|
|
||||||||
|
Net cash provided by (used in) operating activities
|
673.4
|
|
|
(93.7
|
)
|
|
(1.0
|
)
|
|
578.7
|
|
|
722.9
|
|
|
(201.0
|
)
|
|
(.9
|
)
|
|
521.0
|
|
||||||||
|
Net cash Provided by (used in) investing activities
|
(69.2
|
)
|
|
(3.4
|
)
|
|
38.8
|
|
|
(33.8
|
)
|
|
(524.3
|
)
|
|
(21.5
|
)
|
|
26.0
|
|
|
(519.8
|
)
|
||||||||
|
Net cash provided by (used in) financing activities
|
(372.0
|
)
|
|
103.8
|
|
|
(37.8
|
)
|
|
(306.0
|
)
|
|
(419.9
|
)
|
|
202.9
|
|
|
(25.1
|
)
|
|
(242.1
|
)
|
||||||||
|
Effect of exchange rate changes on cash and cash equivalents of consolidated T. Rowe Price investment products
|
—
|
|
|
(.7
|
)
|
|
—
|
|
|
(.7
|
)
|
|
—
|
|
|
1.3
|
|
|
—
|
|
|
1.3
|
|
||||||||
|
Net change in cash and cash equivalents during period
|
232.2
|
|
|
6.0
|
|
|
—
|
|
|
238.2
|
|
|
(221.3
|
)
|
|
(18.3
|
)
|
|
—
|
|
|
(239.6
|
)
|
||||||||
|
Cash and cash equivalents at beginning of year
|
1,425.2
|
|
|
70.1
|
|
|
—
|
|
|
1,495.3
|
|
|
1,902.7
|
|
|
103.1
|
|
|
—
|
|
|
2,005.8
|
|
||||||||
|
Cash and cash equivalents at end of period
|
$
|
1,657.4
|
|
|
$
|
76.1
|
|
|
$
|
—
|
|
|
$
|
1,733.5
|
|
|
$
|
1,681.4
|
|
|
$
|
84.8
|
|
|
$
|
—
|
|
|
$
|
1,766.2
|
|
|
Item 3.
|
Quantitative and Qualitative Disclosures About Market Risk.
|
|
Item 4.
|
Controls and Procedures.
|
|
Month
|
|
Total Number of
Shares Purchased
|
|
Average Price
Paid per Share
|
|
Total Number of
Shares Purchased as
Part of Publicly
Announced Program
|
|
Maximum Number of Shares that May Yet Be Purchased Under the Program
|
|||||
|
January
|
|
1,683,579
|
|
|
$
|
91.28
|
|
|
1,651,544
|
|
|
12,696,262
|
|
|
February
|
|
383,634
|
|
|
$
|
93.56
|
|
|
322,406
|
|
|
22,373,856
|
|
|
March
|
|
520,703
|
|
|
$
|
97.98
|
|
|
501,958
|
|
|
21,871,898
|
|
|
Total
|
|
2,587,916
|
|
|
$
|
92.96
|
|
|
2,475,908
|
|
|
|
|
|
Authorization dates
|
|
1/1/2019
|
|
Additional shares authorized
|
|
Total Number of
Shares Purchased |
|
Maximum Number of Shares that May Yet Be Purchased at 3/31/2019
|
||||
|
December 2016
|
|
4,347,806
|
|
|
—
|
|
|
(2,475,908
|
)
|
|
1,871,898
|
|
|
April 2018
|
|
10,000,000
|
|
|
—
|
|
|
—
|
|
|
10,000,000
|
|
|
February 2019
|
|
—
|
|
|
10,000,000
|
|
|
—
|
|
|
10,000,000
|
|
|
|
|
14,347,806
|
|
|
10,000,000
|
|
|
(2,475,908
|
)
|
|
21,871,898
|
|
|
Item 5.
|
Other Information.
|
|
3(i)
|
|
|
|
|
|
|
|
3(ii)
|
|
|
|
|
|
|
|
15
|
|
|
|
|
|
|
|
31(i).1
|
|
|
|
|
|
|
|
31(i).2
|
|
|
|
|
|
|
|
32
|
|
|
|
|
|
|
|
99.1
|
|
|
|
|
|
|
|
101
|
|
The following series of unaudited XBRL-formatted documents are collectively included herewith as Exhibit 101. The financial information is extracted from T. Rowe Price Group’s unaudited condensed consolidated interim financial statements and notes that are included in this Form 10-Q Report.
|
|
|
|
|
|
|
|
101.INS XBRL Instance Document
|
|
|
|
|
|
|
|
101.SCH XBRL Taxonomy Extension Schema Document
|
|
|
|
|
|
|
|
101.CAL XBRL Taxonomy Calculation Linkbase Document
|
|
|
|
|
|
|
|
101.LAB XBRL Taxonomy Label Linkbase Document
|
|
|
|
|
|
|
|
101.PRE XBRL Taxonomy Presentation Linkbase Document
|
|
|
|
|
|
|
|
101.DEF XBRL Taxonomy Definition Linkbase Document
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|